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ABSTRACT
Introduction: Anemia during preconceptional period was relatively neglected issues. The other
issue is the efficacy of single micronutrient versus multi-micronutrients supplementation.
Objective: This study aims to evaluate the effect of multi micronutrient (MMN) supplementation
during preconceptional period among the newly married women on hemoglobin level during
pregnancy.
Methods: A randomized double blind community-based trial had been conducted at Probolinggo
District, East Java. Newly married women were recruited as stydy subjects, and randomly
assigned into two group: Group I (MMN group) received mutlti micronutrient containing 14
micronutrients 2 other days during preconception, continue with daily dose during pregnancy.
Group II (IFA group) received placebo during preconception period and continue with daily
iron & folat during pregnancy. Total of 420 eliglible subjects were enrolled to meet
approximately 120 pregnancy. The outcome variables is level in week 12, week 28 and week 35
of pregnancy. Social economic background, body mass index, and blood pressure also being
assessed as base line data. Nutrients intake also been assesed in each trimester. Base line data
was analyzed by using independent-t test and multivariate analysis by general linear model to
compare mean differentiation between MMN group and IFA group. Statistical analysis to
hypothetical testing has been done to examine effect of treatment on hemoglobin level of MMN
group and IFA group.
Result: The baseline characteristic between two groups were not different, indicating that two
groups are comparable ( Box’s M value = 44.95 and p = 0.65; Hotelling's Trace T
2
value =
0.094, F = 1.098 and p = 0.371). There were no significant different hemoglobin level in week
12 (p=0.191), week 28 (p=0,655), and week 35 (p=0,865) between MMN group and IFA group.
The average of hemoglobin level at last pregnancy (week 35) more than 11 g/dL in both groups.
Conclusion: Prolonging supplementation of MMN during preconception will protect anemia or
decreasing hemoglobin level less than 11 g/dL as affective as IFA supplementation at last
pregnancy, although it still can not increase the hemoglobin level for non anemic women before
pregnancy.
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INTRODUCTION
Anemia is the one of common nutritional problems among pregnant women and women
in reproductive age in developing countries, due to low micronutrient status. Most of anemia
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cases in developing countries, including in Indonesia, were suggested due to low intake of iron
from food, therefore the rational intervention to combat anemia was by iron supplementation. In
fact, as far as the universal distribution of iron pills program have been implemented to reduce
the prevalence of anemia in Indonesia, until now the reduce rate of the prevalence was not as
effective as the program planed. Even, this program have been supporting by other programs
such as diet modification, iron fortification, and parasite control (Gillspie et al, 1991).
Although there was a decrease prevalence of anemia in Indonesia, but the prevalence in
all age groups was still more than the trigger level of public health problem. There is an increase
trend of prevalence of anemia in Indonesia throughout along life cycle. The prevalence of
anemia among unmarried women in reproductive age was about 24,5%, and increase become
26,9% among married women, then increase twice become 50% when the women entering
pregnancy period, and the highest prevalence of anemia was found among children under five
years. Of children under five years, there was the evidence that the younger children were found
the higher prevalence of anemia. The anemia prevalence among babies less then 6 months was
61,3%, prevalence among babies 6-11 months was 64,8%, and prevalence begin to decline
among children more then 12 months (Atmarita, 2005; Murniningtyas and Atmawikarta, 2006).
The data trend of anemia seems to be viewed as a continuum of maternal micronutrient
status throughout life cycle, especially from the preconceptional period through lactation, and of
fetal and infant dependency on adequate maternal status through this time. It’s also reflects the
intergenerational cycle of anemia. The high anemia prevalence among pregnant women may be
caused by they were anemic before pregnant, and the high prevalence of anemia among less
then 12 months babies may due to low maternal iron status. It was suggested by De Pee et al
(2002), that highest prevalence of anemia was found among babies 3-5 months who delivered by
the anemic mother. Based on these data and according to Allen (2005), anemia in Indonesia
actually should be viewed as a continuum of 3 stages in life cycle: preconceptional, pregnancy
and postpartum periods. This data also emphasize the importance of iron status before pregnancy,
not just during pregnancy.
Beside of intergenerational cycle problems, it may indicate that anemia in Indonesia
does not caused by single nutrient deficiency. It is a rationale reason, because biosynthesis of
hemoglobin in the human body is not only need iron alone, but also need the other
micronutrients that involve in iron metabolism, such as vitamin A, zinc, vitamin B, vitamin C
and cuprum (Devlin, 2001). Vitamin A was needed to produce transferrin, an iron-binding
protein that transport iron into the body cells (Semba and Bloem, 2002). Zinc is an important
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compound of δ-aminolevulinic acid (ALA) synthase, an enzyme that involve in the first step of
sequence reaction of heme biosynthesis from glycine and succinyl-CoA which produced by three
carboxylic acid (TCA) cycle (Wolfson, 1978). Deficiencies of thus micronutrients can also cause
anemia, and iron supplementation alone does not effective to reduce the prevalence of anemia if
the other micronutrients deficiencies were not considered.
Based on thus issues, this research focus to evaluate the effect of multi micronutrient
(MMN) supplementation during preconceptional period on improving maternal iron status
during pregnancy.
METHODS
This is a randomized double blind community-based trial (Altman et al., 2001; Moher et
al., 2010). The study setting at District of Probolinggo East Java, was chosen because
prevalence of anemia and adverse pregnancy outcome was high in this area (Sri Sumarmi et al.,
2008a; Sri Sumarmi et al, 2008b). Study subject were newly married women from selected 9
sub districts and randomly assigned into two group: Group I received mutlti micronutrient MMN
UNIMMAP formulation (Shankar et al., 2008), it’s containing 14 micronutrients 2 other days
during preconception, and continue with daily dose during pregnancy. Group II received placebo
during preconception period and continue with daily iron and folat (IFA), containing 60 mg iron
and 250 μg folic acid only during pregnancy.
Sample size was calculated base on a sample fomula (Pocock, 1983). A sample size of
46 was required for each group on the basis of mean size effect 3.7 g/L and SD 1.7 of
hemoglobin level (Muslimatun et al., 2001). By considering the proportion of newly married
women with time to pregnancy less than 7 months was 45% (Nurdiati, 2001), we need to enroll
102 subjects each group and when we allow 20% of loss of follow, then need 128 newly married
women are required in each group. Total eliglible subjects enrolled in this study were 256.
Randomization has been carried out by using a random permuted blokcs method with block size
of 10, and allocation ratio 1:1, then we have equal subjects of 128 each group (Meinert, 1986).
The primary outcome variable is maternal hemoglobin level, at week-12, week-28 and
week 36. Hemoglobin was determined from sample of approximately 10 μL capilary whole
blood that drawn with HemoCue Hb 201 microcuvettes, analyzed using a protable hemoglobin
meter kid HemoCue® AB, Anglehome, Sweden). Hemoglobin concentration being colected
fourtimes, at enrollement of participants as baseline data, early pregnancy (week 12th) and week
28th of pregnancy as midline data and week 36th of pregnancy as endline data. Variable of Hb
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then categorized as dichotomous data using single cut off point 12 g/dL (before pregnancy) and
11 g/dL (during pregnancy). Social economic background, nutritional status including body mass
index and mid uper arms circumferences (MUAC), dietary intake, and blood pressure also being
assessed as base line data. BMI was expressed as weight (kg) divided by the square of height
(m). Body weight is measured by using digital body scale Seca® type 803, with increment of
100 g. Height or stature is measured by using microtoise with 0.1 cm increment. MUAC was
measured by using fiber tape (Unicef), with increment of 0.1 cm. Dietary intake was
determined using 24 hours dietetic recall to calculate the daily intake of energy, protein, some
vitamin and minerals. Interview using questionares and supporting tools such as food model and
house hold utensil will be carried out four times at enrollement of participants as baseline data,
early pregnancy (week 12th), week 28th of pregnancy and week 36th of pregnancy. Data of
nutrient intake was analyzed using sofware Nutrisurvey, and the intake value then being
compared to the Indonesian recommended dietary allowance.
Base line data was analyzed by using independent-t test to compare mean differentiation
between treatment group and control group. Statistical analysis using t test to hypothetical testing
has also been done to examine effect of treatment on hemoglobin level at week-12, week-28 and
week-36 using.
RESULTS
Subjects Enrollment
To cover 256 eligible subjects, we screened out of 978 newly married women. Of the
entire subjects who screened, there were 519 newly married women who did not desire to have a
child in the first year and use contraception were excluded. Then 459 newly married women
who want to have a child in the first year of marriage were continue to the next phase. In the
early selection by midwives, 123 married women were not eligible for next phase because they
getting pregnant base on rapid test for human chorionic gonadotropin in urine for detecting
pregnancy (77) or did not stay at study areas (46). The next step then 336 married women had
physical examination and pregnancy test. Of subjects who continued to physical examination,
there were 80 women were not eligible since 3 women had tuberculosis infection, 2 women
suspect of diabetes mellitus and 75 women were already pregnant. Therefore 258 women were
eligible to enroll the study (Figur 1).
All the eligible subjects then randomly assigned into two groups (MMN group and IFA
group). In MMN group there were total of 95 pregnant subjects, which are 38 subjects getting
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pregnant before 2 months of intervention, and 57 subjects were pregnant after received 2 months
of intervention. Total pregnant subjects in control group were 106, which are 48 subjects getting
pregnant before 2 months of intervention, and 58 subjects were pregnant after received 2 months
of intervention. Subjects who pregnant before 2 months of intervention were not intensively
follow up, and subjects who pregnant after received 2 months of intervention were intensively
follow up. Figure 1 performs the flow chart of entire eligible subjects who enrolled and
randomized into two groups.
Characteristics of Treatment (MMN) Group and Control (IFA) Group
The social economic characteristic of the subjects were social economic status, marriage
status, such as age, education level, occupation and income. Data will be discussed descriptively
and compared between MMN group and IFA group.
Tabel 1. Social economic characteristic of MMN group and IFA group
Characteristics
MMN Group
(n = 57)
IFAGroup
(n = 58)
Age
< 20 years 25 (43.9%) 15 (25.9%)
20 – 25 years 25 (43.9%) 30 (51.7%)
> 25 years 7 (12.3%) 13 (22.4%)
Education level
No schooling at all 1 (1.8%) 0 (0%)
Elementry school 8 (14.0%) 9 (15.5%)
Junior High school 13 (22.8%) 16 (27.6%)
Senior High school 29 (50.9%) 19 (32.8%)
Graduate of university/collage 6 (10.5%) 14 (24.1%)
Occupation
No occupation 39 (68.4%) 37 (63.8%)
Teacher 4 (7.0%) 12 (20.7%)
Health practices 2 (3.5%) 1 (1.7%)
Civil servant 1 (1.8%) 0 (0.0%)
Industrial worker 8(14.0%) 5 (8.6%)
Others 3 (5.4%) 3 (5.1%)
Income
< 500,000 9 (50.0%) 13 (61.9%)
500,000 – 1,000,000 5 (27.8%) 8 (38.1%)
> 1,000,000 - 2,000,000 3 (16.7%) 0 (0.0%)
> 2,000,000 1 (5.6%) 0 (0.0%)
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Screening for eligibility
(n = 976, from 9 subdistrict areas)
Physical and pregnancy test
(n = 336)
Subjects who desire to have child in 1st years were
continued in screening process
(n= 459)
Excluded because didn’t want to have
child in 1st year / contraceptive use
(n = 519)
Excluded in early selection by midwives
in village level (n = 123)
Getting pregnant (n=77)
Move out from research area (n=46)
Excluded (n = 80)
Pregnant (n=75)
Suspect to Diabetes Millitus (n=2)
Detected Tubercolusis infection (n=3)
Randomized
(n = 256)
Allocated into treatment Group
Received MMN 1 day intermittent
(n = 128)
Allocated into control group
Received placebo 1 day intermittent
(n = 128)
Pregnant < 2 mo
intervention
(n = 38)
Pregnant ≥ 2 mo
intervention
(n = 57)
Pregnant < 2 mo
intervention
(n = 48)
Pregnant ≥ 2 mo
intervention
(n = 58)
Week-28
(n = 56)
Week-12
(n = 56)
Week-28
(n = 53)
Week-12
(n = 55)
Non Intensive
follow up
Continue receive
Iron & folic acid
pill from program
Non Intensive
follow up
Continue receive
Iron & folic acid
pill from program
Intensive follow up
Continue recieve MMN
daily
Intensive follow up
Continue recieve IFA
daily
Preconception
Period
Preconception
Period
Figure 1. Flow chart of subjects
Week-36
(n = 45)
Week-36
(n = 54)
Fetal loss
(n = 2)
Premature (n = 2)
Loss of follow up (n= 6)
Premature (n = 1)
Loss of follow up (n= 1)
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Baseline Data of MMN Group and IFA Group
The baseline data of primary variable between MMN group and IFA group are compared
descriptively. The primary variables discussed are nutritional status including body size such as
body weight, height, MUAC, as well as blood pressure and blood glucose and hemoglobin level.
Those data represent preconceptional condition among MMN group and IFA group. More
detailed data are performed in table 2.
Table 2. Baseline data of MMN group and IFA group
Nutritional Status MMN Group n=57 IFA Group n=58
BMI
Under weight 13 (22.8%) 14 (24.1%)
Normal weight 39 (68.4%) 35 (60.3%)
Over weight 4 (7.0%) 7 (12.1%)
Obese 1 (1.8%) 2 (3.4%)
Body Weight
< 40 kg 11 (19.3%) 10 (17.2%)
≥ 40 kg 46 (80.7%) 48 (82.8%)
Height
< 145 cm 8 (14.0%) 10 (17,2%)
≥ 145 cm 49 (86.0%) 48 (82.8%)
MUAC
< 23.5 cm 18 (31,6%) 19 (32.8%)
≥ 23.5 cm 39 (68.4%) 39 (67.2%)
Hemoglobin
< 12 g/dL 21 (36.8%) 17 (29.3%)
≥ 12 g/dL 36 (63.2%) 41 (70.7%)
Statistical test to compare the homogenity of preconception data between MMN group and
IFA group
Univariate analysis for mean comparation between treatment group and control was done
using independent sample t test. All preconception data which reflect the initial condition
between two groups were tested. Result showed in table 3.
Table 3. Univariate analysis to compare the mean value of several preconception data between
MMN group and IFA group using independent t test.
Variables
MMN Group
n=57
IFA Group
n=58
p value
Age 20.9 ± 3.3 22.4 ± 3.9 0.026
Body Weight 47.4 ± 8.1 47.3 ± 9.2 0.920
Stature 150.9 ± 5.6 149.9 ± 5.7 0.308
MUAC 25.2 ± 3.3 25.3 ± 3.8 0.833
BMI 20.8 ± 3.5 21.0 ± 3.8 0.805
Systole 106.2 ± 8.9 106.2 ± 9.9 0.978
Diastole 70.7 ± 8.7 70.1 ± 8.4 0.727
Hb 12.2 ± 1.1 12.6 ± 1.2 0.112
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Nutrient intake was analyzed separately. Comparation of nutrient intake between MMN
group and IFA group is performed in Table 4.
Table 4. Univariate analysis to compare the mean value of preconception nutrients intake
between MMN group and IFA group using independent t test.
Nutrient
MMN Group
n=57
IFA Group
n=58
p value
Energy (cal) 1575 ± 375 1576 ± 478 0.996
Protein (g) 59.4 ± 17.7 59.8 ± 22 0.921
Fat (g) 65.5 ± 21.3 66.7 ± 27.7 0.801
Carbohidrate (g) 188 ± 59 181 ± 76 0.542
Dietary fiber (g) 8.2 ± 3.6 7.3 ± 3.7 0.179
Vit A (µg) 864 ± 885 845 ± 744 0.897
Thiamin (mg) 0.6 ± 0.2 0.6 ± 0.3 0.750
Ribovlavin (mg) 0.7 ± 0.3 0.6 ± 0.3 0.334
Piridoxine (mg) 0.9 ± 0.3 1.0 ± 0.4 0.866
Folic acid (μg) 118 ± 55 115 ± 63 0.828
Vitamin C (mg) 29.5 ± 30.4 22.6 ± 30.4 0.188
Iron (mg) 7.8 ± 2.9 7.6 ± 3.5 0.795
Zinc (mg) 7.3 ± 2.0 7.6 ± 3.0 0.571
Nutrient intake is also similar between treatment group and control group. There is no
significant difference of preconception energy protein intake and other macronutrients intake
such as carbohydrate, total fat and dietary fiber between two groups (table 4). The mean value of
several micronutrients intake is also demonstrated similar result (p > 0.05).
Effect of Treatment on Maternal Hemoglobin Level
In this sub section, we start to discuss the effect of supplementation on maternal nutrition,
and compare it between MMN group and IFA group. Treatment group received MMN during
preconception period then continue during pregnancy (preconceptional MMN group) and control
group received placebo during preconception period then continue with iron folic acid (IFA)
during pregnancy (placebo-IFA group). Time series data of selected variables were performed in
table 5.
A sequence of observation had been done in week-12, week-28 and week-35/36 to assess
several data of subjects within MMN group and IFA group. The average of body weight in
treatment group is increase from 47.42 kg before conception to 56.99 kg in week 35 -36, and
provide weight gain of 9,57 kg in last trimester. Weight gain of subjects in MMN group is
slightly higher compare to control group. The average of body weight in IFA group is increase
from 47.26 kg before conception to 56.40 kg in week 35-36, weight of 9.14 kg.
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Table 5. Times series data of subjects within MMN group and IFA group
Variables
Preconception
n=57
Week-12
n=56
Week-28
n=56
Week-35/36
n=54
d
MMNGroup
Body weight (kg) 47.4 ± 8.1 49.3 ± 8.3 52.9 ± 7.9 57.0 ± 8.2 + 9.6
MUAC (cm) 25.2 ± 3.3 25.4 ± 3.2 25.9 ± 3.1 26.2 ± 3.3 + 1
Systole (mmHg) 106.2 ± 8.9 112.5 ± 5.5 110.7 ± 6.6 111.7 ± 6.1 + 5.5
Diastole (mmHg) 70.7 ± 8.7 74.1 ± 5.9 75.2 ± 7.6 73.9 ± 5.9 + 3.2
Hb level (g/dL) 12.2 ± 1.1 12.1 ± 0.7 11.8 ± 0.6 11.9 ± 0.3 - 0.3
IFA Group
Body weight (kg) 47.3 ± 9.2 49.0 ± 8.9 53.6 ± 8.9 56.4 ± 0.1 + 9.1
MUAC (cm) 25.3 ± 3.8 25.4 ± 3.5 26.1 ± 3.59 26.3 ± 3.2 + 1
Systole (mmHg) 106.2 ± 9.9 112.9 ± 6.6 110.7 ± 7.1 112.3 ± 7.9 + 6.1
Diastole (mmHg) 70.1 ± 8.4 76.4 ± 6.2 76.6 ± 5.9 75.5 ± 5.8 + 5.4
Hb level (g/dL) 12.6 ± 1.2 12.3 ± 0.8 11.9 ± 0.8 11.9 ± 0.8 - 0.7
Effect of intervention on hemoglobin level is demonstrated in figure 2. Average of
hemoglobin concentration tends to decrease in both groups. The initial Hb level of subjects
within IFA group (control group) is higher compare to those in MMN group (treatment group),
with the mean difference of 0.4 g/dL, then decrease in week-12 with mean difference of 0.2 g/dL,
continue decrease until week-28, with mean difference of 0.1 g/dL.
Figure 2. Average of hemoglobin concentration along gestation age between treatment (MMN)
group and control (IFA) group.
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Table 6. Statistical analysis using independent t test for hypothetical testing of effect of
treatment on hemoglobin level at baseline, week-12, week-28 and week-36 between
MMN group and IFA group.
Parameter t df Mean difference Sig.(two tailed)
Hb level Baseline -1.601 113 -0.337 0.112
Hb level in week-12 -1.315 109 -0.195 0.191
Hb level in week-28 -0.447 107 -0.062 0.655
Hb level in week-28 -0.171 97 -0.026 0.865
Figure 3. Average of hemoglobin concentration along gestation age among anemic and non
anemic subject within MMN group and IFA group.
Base on statistical analysis, there were no significant different hemoglobin level in week
12 (p=0.191), week 28 (p=0,655), and week 35 (p=0,865) between MMN group and IFA group.
The average of hemoglobin level at last pregnancy (week 35) more than 11 g/dL in both groups
(table 6). Figur 3 shows the comparation of Hb level among anemic subjects and non anemic
subject in in MMN group and IFA group.
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DISCUSSION
Statistical analysis using independet t test demonstrated that there is no significant
differences of each variable between two groups. The mean value of most variables such as
preconception body mass index and several body size including body weight, height, mid upper
arms circumference, as well as hemoglobin level and blood pressure are comparable between
subjects within treatment and control group (p > 0.05), unless age (p=0.026) is significantly
different between two groups.
The average of energy intake in both group was less than dietary recommendation for
Indonesian reference population, especially for women 16-29 years age (1900–2200 kcal/day).
Energy intake among subjects in two groups is only reach of 70%-80% of the Indonesian
recommended dietary allowences (RDA). Protein intake was adequate to meet their body
requirement, because the average of protein consumption among subjects in treatment and
control groups was 59.4 g and 59.8 g, respectively. This intake is higher than protein
recommendation for these reference group (50 g/day). Most of micronutrients intake were less
than dietary recommendation. Base on statistical evidence, it indicates that no significant
differences of preconception characteristic of subjects between treatment group and control
group. Therefore, it can be concluded that the two groups are comparable. We expect that any
differences on several prospective outcomes it would be effect of the intervention.
From figure 2, we can see that the decreasing pattern of hemoglobin concetration is very
interesting, because the mean difference between two group is tend to smaller according to
gestation age, and finally no difference Hb level in week-35. These findings indicate that
compare to iron folate, MMN supplementation provide efective elevation of Hb level particularly
in last trimester. The decrease of hemoglobin concentration is follow the pattern of expansion in
blood volume, but negatively corelated. In normal pregnancy, progressive decrease of
hemoglobin concentration in second trimester (week 12-week 28), as physiological effect of
progressive increase in plasma volume, and has usually reached a plateau by week 28 (Carriaga
et al., 1991). Our data demonstrate that Hb concentartion in control group is similar with
Carriaga findings, that Hb level reached a plateau by week-28 and after. But in our treatment
group, Hb level tends to increase by week-28. This elevation must be as the effect of MMN
supplementaion.
When we focus in effect of treatment within group or before and after treatment, our
result demonstrated a different evidence with the finding from study at West Java. This study
revealed that at near term pregnant women who received weekly vitamin A and iron had
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significantly higher hemoglobin concentration compared with baseline. The hemoglobin
concentration of anemic subjects (hemoglobin < 11 g/dL) increased from baseline by 1.07 g/dL
in the weekly vitamin A and iron group, by 0.66 g/dL in the weekly iron group (p< 0.01) and by
0.34 g/dL in the daily group (p< 0.05). The increase of hemoglobin concentration in anemic
subjects in the weekly vitamin A and iron group was significantly higher than in the daily group
(p< 0.05). The hemoglobin concentration in nonanemic subjects did not change, and decreased
from baseline by 0.41 g/dL in the daily group (Muslimatun et al. (2001). Our data more likely
support a part of this finding. On the basis of initial hemoglobin concentration of our subjects at
preconception, it was categorized non anemic (>12 g/dL), thus hemoglobin did not increase but
decrease from baseline by 0.48 g/dL in both groups.
Figur 3 performs the interesting evidence that supplementation only works for anemic
subjects, both of MMN and also IFA. During preconception period until week-12 of pregnancy,
hemoglobin level of the anemic subjects increases progressively in both groups. Among anemic
subject in MMN group, at week-12 there is increasing hemoglobin level of 0,76 g/dL from
baseline, and increasing of 0.54 g/dL among IFA group. The interesting evidence is hemoglobin
level among anemic subjects in IFA group after week-12 decrease until week-28 and then get
plateau. On the other hand hemoglobin level among anemic subjects in MMN group after week-
12 get plateau until week-28 and the slightly increase at week-36.
Base on statistical result in table 6, it implies that the eficacy of MMN preconception on
iron status as efective as iron folic acid (IFA). More over, we have more detailed explanation
descriptively, that in last terimester when hemoglobin concentration generally reached plateau in
control group who recieved IFA, meanwhile subjects in treatment group who recieved MMN
have increasing hemoglobin. It mean that process of erythropeisis during last trimester more
efective in subject who received MMN. This condition more likely due to increasing iron
mobilization which indicated by greater elevation of sTfR in treatmeant group rather than in
control group. The increasing of iron mobilization might due to better vitamin A status among
subjects within treatment group.
CONCLUSION
Prolonging supplementation of MMN during preconception will protect anemia or
hemoglobin level less than 11 g/dL as affective as IFA supplementation during pregnancy which
are represented by hemoglobin level at week-12, week-28 and week-36 of pregnancy. Both of
intervention, whether supplementation of MMN or IFA, only works to increase hemoglobin level
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for the anemic subject before pregnancy, but it still can not increase the hemoglobin level for non
anemic women before pregnancy.
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